Company news

PureTech Health PLC news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

PRTC Presents LYT-200 Phase 1b Data in AML at ASH

December 9, 2024

PRTC's Seaport Adds Microsoft and J&J Exec to BOD

November 20, 2024

PRTC's Seaport Adds Biotech Finance Exec as CFO

November 5, 2024

Director/PDMR Shareholding

October 31, 2024

PRTC to Present at UBS and Jefferies Conferences

October 30, 2024

PRTC's Seaport Closes $225M Series B Financing

October 21, 2024

PRTC's IPF Patient Research & Ph 2b On Track YE24

October 9, 2024

PRTC to Give 3 Presentations at CHEST 2024 Meeting

October 1, 2024

KarXT/Cobenfy Approved by FDA; PRTC Receives $29M

September 27, 2024

PRTC's Vor Shares New AML Data Validating Approach

September 6, 2024

Results of AGM on 13 June 2024 – Update Statement

August 28, 2024

PRTC Adds Industry Leader to Board of Directors

August 22, 2024

PRTC's Seaport Appoints Global Pharma Exec to BOD

August 13, 2024

PRTC'S Vedanta Expands Leadership Team

July 23, 2024

Completion of Tender Offer & Total Voting Rights

June 24, 2024

Result of Tender Offer

June 24, 2024

Director Declaration

June 20, 2024

PRTC's Seaport Appoints Seasoned Execs to Team

June 18, 2024

Result of Meeting

June 6, 2024

Additional Disclosure Re: Tender Offer

June 4, 2024

PRTC's Akili Enters Into Merger Agreement

May 29, 2024

PRTC's Vedanta Begins Phase 3 of VE303 in C. diff

May 21, 2024

Tender Offer

May 20, 2024

PRTC's Seaport Presents Ph1 and Ph2a SPT-300 Data

May 9, 2024

PRTC's Seaport Announces Board/Team Appointments

May 7, 2024

PRTC LYT-100 Ph2b in IPF Enrolled; Results Q4 2024

April 16, 2024

FDA Grants PRTC's LYT-200 Fast Track Designation

April 11, 2024

PRTC Launches Seaport w/ $100M; Leadership Changes

April 9, 2024

$100M Tender Offer

March 19, 2024

$14B Acquisition of PRTC’s Karuna by BMS Completed

March 18, 2024

FDA Grants PRTC's LYT-200 Orphan Drug Designation

March 13, 2024

PRTC to Present at Cowen and Leerink Conferences

February 27, 2024

PRTC: Akili Positive Ph3 & Japan PMDA Submission

February 27, 2024

Transaction in Own Shares

February 8, 2024

PureTech to present at the JP Morgan Conference

January 3, 2024

BMY Acquires PRTC Founded Entity Karuna for $14B

December 22, 2023

PRTC Year End Update & Outlook for 2024

December 20, 2023

New LYT-200 Solid Tumors Data Presented at ESMO-IO

December 7, 2023

PRTC: Karuna's NDA for KarXT Accepted by U.S. FDA

November 29, 2023

Karuna's Blood Pressure Trial of KarXT Successful

November 17, 2023

PRTC Achieves Primary Endpoint in Anxiety Trial

November 14, 2023

PRTC to Present at Upcoming Conferences + Progress

October 17, 2023

New LYT-100 Data from Phase 1 Trials at Conference

October 11, 2023

Vedanta VE202 Ph2 Starts + Fast Track Designation

October 4, 2023

KarXT-invented at PRTC-submitted for FDA Approval

September 28, 2023

PRTC Names Robert Lyne as Chief Portfolio Officer

September 27, 2023

PRTC Gets $11.4M Grant for Ph2 of LYT-300 in FXTAS

August 1, 2023

PureTech Begins Ph2a Trial of LYT-300 for anxiety

June 21, 2023

Akili Releases EndeavorOTC - Adult ADHD Treatment

June 7, 2023

PureTech to Present at Jefferies Healthcare Conf

May 24, 2023

← Newer news releases · Older news releases →

Calls

The 5 newest of 6 calls. Every call is listed under its year.

Decks

The 5 newest of 7 decks. Every deck is listed under its year.